the aid library

LIST OPTIONS

Filter

8396

Monkeypox Case Report Form (CRF) (Arabic)

World Health Organization WHO (2022) C_WHO

21 July 2022. The Rapid Core CRF is designed to collect data obtained through examination, interview and review of hospital or clinic notes of patients with suspected, probable, or confirmed monkeypox infection. Data may be collected prospectively or retrospectively. The data collection period is ... more

Download (379)

View PDF (295)

Antibiotic Guidelines, 2019 (First edition) - Myanmar

World Health Organization WHO (2019) C_WHO

This is the first edition of Empiric Antibiotic Guidelines, as a guidance to all medical practitioners at North Okklapa General & Teaching Hospital. Antibiotics are critical in the management of infection and can have a significant impact in reducing morbidity and mortality. Emerging antimicrobia... more

External Link

COVID-19 Projections Bolivia

Institute for Health Metrics and Evaluation (2022) C2

Website last accessed on 08.09.2022 Explore forecasts of COVID-19 cases, deaths, and hospital resource use.

Download (152)

View PDF (203)

Patient safety assessment manual
recommended

World Health Organization WHO (2022) C_WHO

3rd edition. Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards and assessment criteria that reflect current best practice and WHO gu... more

Download (159)

View PDF (183)

Rapport sur l’Atelier de mise en œuvre de partenariat

Partenariats africains pour la sécurité des patients (APPS) ; Organisation Mondiale de la Santé (2010) C_WHO

L’Atelier de mise en œuvre de partenariat constitue une étape importante pour les Partenariats africains pour la sécurité des patients. Les équipes de chaque hôpital africain, suisse et anglais participant au programme ont assisté à l’atelier dans le but de travailler ensemble dans leur... more

Download (285)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Rehabilitation Task Force Technical Note: Spinal Cord Injury Care in Gaza

Health Cluster; World Health Organization WHO (2024) C_WHO

The war in Gaza has resulted in many hundreds of spinal cord injuries (SCI), which will have a devastating impact on those injured and their families for the rest of their lives. The optimal management of SCI requires effective pre-hospital care, early specialized imaging (using CT or MRI) and in... more

Mpox Outbreak in Uganda Situation Update - 09 October 2024

World Health Organisation (WHO) (2024) C_WHO

Uganda confirmed the first cases of mpox on 24 July 2024 following the confirmation of two case-patients from Kasese District, Bwera Hospital by the Uganda Virus Research Institute (UVRI) through a routine sentinel surveillance system. Cumulatively, 80 confirmed cases of mpox have been registered.

Birth defects surveillance training: facilitator’s guide, second edition

World Health Organisation (WHO) (2024) C_WHO

This Birth Defect Surveillance facilitator (train-the-trainer) guide 2nd edition covers foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomaly surveillance programme, whether population-based or hospital-based, in particular for countries ... more

Download (7035)

View PDF (1589)

Manuel Qualité Service Pharmacie

Centre Hospitalièr d'Aubenas (2005) CC

Ce manuel décrit les règles et les procédures mises en place pour assurer la qualité des prestations faites par le service de Pharmacie de l’hôpital d’Aubenas. Il s’applique à toutes les prestations faites par le service de Pharmacie à destination des différents services de l’hôp... more

Download (1049)

View PDF (2731)

Mobilisons-nous contre l'Ebola (Textes SMS)

Ministere de la Santé et de la Lutte Contre le SIDA (2014)

L’Ebola est mortel. En cas de fièvre, diarrhée, vomissement, saignement, allez vite à l’hôpital, appelez 143 ou 101. Consultez www.prevention-ebola.gouv.ci (158 caractères) L’Ebola est mortel. Lavez-vous régulièrement les mains au savon. Désinfectez tout à l’eau de javel. Signal... more

Download (218)

View PDF (160)

Prise en charge clinique de la COVID-19 : orientations évolutives, 23 juin 2022
recommended

World Health Organization WHO (2022) C_WHO

Ce document d'orientation est destiné aux cliniciens qui s'occupent de patients atteints de COVID-19 à toutes les phases de leur maladie (c'est-à-dire du dépistage à la sortie de l'hôpital). Cette mise à jour a été étendue pour répondre aux besoins des cliniciens de première ligne et fa... more

External Link

Palliative Care E-learning Course for Healthcare Professionals in Africa

Ecancer Education (2014) CC

ecancer, Cardiff University and the African Palliative Care Association have developed an online course in palliative care contextualised for African healthcare professionals. The course has been created through the IAEA Programme of Action for Cancer Therapy, Virtual University of Cancer Control a... more

Download (1131)

View PDF (2317)

Cuidados Hospitalares para Criancas

World Health Organization (2008) C_WHO

Este livro em formato prático é dirigido a médicos, enfermeiros e demais profissionais de saúde responsáveis pelo cuidado de crianças no primeiro nível de referência em países em desenvolvimento. Apresenta diretrizes clínicas atualizadas que se baseiam na revisão da evidência publicada d... more

Download (1409)

View PDF (2035)

How to safely conduct burial of patient who has died from suspected or confirmed Marburg or Ebola viurs disease: field situation

World Health Organization (2014)

This protocol provides information on the safe management of dead bodies and burial of patients who died from suspected or confirmed Ebola virus disease. These measures should be applied not only by medical personnel but by anyone involved in the management of dead bodies and burial of suspected o... more

Download (1478)

View PDF (4665)

How to conduct safe and dignified burial of a patient who has died from suspected or confirmed Ebola or Marburg virus disease

World Health Organization WHO (2014) C_WHO

This protocol provides information on the safe management of dead bodies and burial of patients who died from suspected or confirmed Ebola or Marburg virus disease. These measures should be applied not only by medical personnel but by anyone involved in the management of dead bodies and burial of su... more

External Link

Health Care in Danger - Online Courses

International Committee of the Red Cross ICRC (2014)

New E-learning on health care responsibilities in times of conflict Are you a doctor wondering how to interact with the media, or a nurse wondering how to treat patient information in difficult circumstances? Are you an ambulance driver unsure of what your responsibilities are? Are you a hospital a... more

Ebola virus disease preparedness strengthening team Cameroon Country Visit 10 to 14 November

World Health Organization (2014)

The immediate objective of the country visit to Cameroon was to ensure that the country is as operationally ready as possible to effectively and safely detect, investigate and report potential Ebola virus disease cases and to mount an effective response that will prevent a larger outbreak. After te... more

Download (1302)

View PDF (2328)

Good Pharmacy Practice - Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services

World Health Organization (WHO), International Pharmaceutical Federation (FIP) (2011) C_WHO

WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na... more

Patient safety assessment manual recommended

Prise en charge clinique de la COVID-19 : orientations évolutives, 23 juin 2022 recommended

Patient safety assessment manual
recommended

Prise en charge clinique de la COVID-19 : orientations évolutives, 23 juin 2022
recommended